InvestorsHub Logo

ash111

06/10/16 10:14 AM

#1134 RE: tongly #1133

OXGN this is a $10 stock on the works imo. "Showing superior effectiveness, effect on serious outcomes or improved effect on serious outcomes
Avoiding serious side effects of an available therapy
Improving the diagnosis of a serious condition where early diagnosis results in an improved outcome
Decreasing a clinical significant toxicity of an available therapy that is common and causes discontinuation of treatment
Ability to address emerging or anticipated public health need"

http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm

cap is under $20m and the balance sheet very solid,even rare.assets/debt ratio=12!!